local_hospital

ze:ro Praxen MVZ fuer Innere Medizin GmbH

Address
Bergstrasse 49, 69469 Weinheim, Germany

Digestive System Diseases Research

At ze:ro Praxen MVZ fuer Innere Medizin GmbH in Weinheim, clinical research in digestive system diseases focuses on colon cancer. The studies are designed to better understand how treatment strategies can improve outcomes for people with locally advanced disease, with the goal of refining care before and after surgery.

  • Evaluating whether preoperative chemotherapy can improve treatment effectiveness in colon cancer
  • Comparing treatment approaches for resectable colorectal cancer to support better surgical planning

This work centers on testing a new treatment strategy and helping define the most effective sequence of care for patients with advanced colon cancer.

Congenital, Hereditary, and Neonatal Diseases Research

Clinical trial activity also includes congenital and hereditary diseases, with a focus on homeostatic iron regulator gene-related hereditary hemochromatosis. This research aims to improve the management of iron overload by assessing whether treatment can reduce excess iron in the liver and support safer long-term care.

  • Studying hereditary hemochromatosis to improve control of iron overload
  • Assessing changes in liver iron concentration as a marker of treatment effect

The trial work here is focused on evaluating a therapy for HFE-related hereditary hemochromatosis and improving how this inherited condition is monitored and treated.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
7
IMPs

Activity Indicator

Last 6 months

1
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_upGrowing+100%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
2
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
2
Outperforms 47% of sites
public
Therapeutic diversity
2areas
Outperforms 62% of sites
groups
Sponsor diversity
2sponsors
Outperforms 51% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in ze:ro Praxen MVZ fuer Innere Medizin GmbH

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Phase 2 Randomized, Placebo-Controlled Study of the Efficacy and Safety of Vamifeport in Adults with HFE-Related Hereditary HemochromatosisCSL Behring LLCPhase IIRecruitingJul 2026

IMP list

lock Showing 1 of 7 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Calcium Folinate1Unknown2025-04-012025-04-01

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.